Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
130.21
-1.07 (-0.82%)
At close: Jul 31, 2026, 4:00 PM EDT
130.02
-0.19 (-0.15%)
After-hours: Jul 31, 2026, 5:38 PM EDT

Gilead Sciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21
6,9607,9257,7697,0826,6677,5697,5456,9546,6867,1147,0516,5996,3527,3897,0426,2606,5907,2447,4216,217
Revenue Growth (YoY)
4.40%4.70%2.97%1.84%-0.28%6.40%7.01%5.38%5.26%-3.72%0.13%5.42%-3.61%2.00%-5.11%0.69%2.60%-2.38%12.83%20.88%
Cost of Revenue
1,4451,6241,5691,5011,5401,5811,5741,5441,5522,0901,5651,4421,4011,3961,3951,4421,4242,6271,2231,390
Gross Profit
5,5156,3016,2005,5815,1275,9885,9715,4105,1345,0245,4865,1574,9515,9935,6474,8185,1664,6176,1984,827
Selling, General & Admin
1,4511,7941,3571,3651,2581,9071,4331,3771,3751,6081,3151,8491,3192,0201,2131,3571,0831,6501,1901,351
Research & Development
1,4792,5231,5161,7421,6321,6303,6501,3898,0811,8051,5481,6431,9281,7061,5971,4323,8862,6961,1661,230
Total Operating Expenses
2,9304,3172,8733,1072,8903,5375,0832,7669,4563,4132,8633,4923,2473,7262,8102,7894,9694,3462,3562,581
Operating Income
2,5861,9843,3272,4742,2372,4528882,644-4,3221,6122,6231,6651,7052,2672,8372,0291979403,8422,246
Interest Expense
-240-255-256-254-260-249-238-237-254-252-232-230-230-226-229-242-238-238-250-256
Other Non-Operating Income (Expense)
235349569208-328-35306-35591293-72152-174-10-176-284-11157-154-173
Total Non-Operating Income (Expense)
-594313-46-588-28468-592-16341-304-78-404-236-405-526-349-181-404-429
Pretax Income
2,5802,0783,6412,4291,6492,1679562,053-4,4861,6532,3181,5881,3002,0312,4321,503-1527593,4381,817
Provision for Income Taxes
559-105589468334385-297438-315237146549316398646368-164383852300
Net Income
2,0212,1833,0521,9601,3151,7831,2531,614-4,1701,4172,1721,0399851,6331,7861,135123762,5861,517
Minority Interest in Earnings
-----0--0-12-8-6-26-7-3-9-7-6-6-5
Net Income to Common
2,0212,1833,0521,9601,3151,7831,2531,614-4,1701,4292,1801,0451,0101,6401,7891,144193822,5921,522
Net Income Growth (YoY)
53.69%22.43%143.58%21.44%-24.77%-42.52%54.45%--12.87%21.86%-8.65%5215.79%329.32%-30.98%-24.84%-98.90%-75.37%620.00%-
Shares Outstanding (Basic)
1,2421,2421,2431,2451,2461,2481,2471,2471,2471,2481,2481,2471,2481,2521,2551,2561,2551,2561,2561,255
Shares Outstanding (Diluted)
1,2541,2531,2541,2551,2591,2591,2541,2511,2471,2561,2571,2581,2611,2641,2611,2601,2621,2621,2621,260
Shares Change (YoY)
-0.40%-0.48%-0.32%0.96%0.24%-0.24%-0.56%-1.11%-0.63%-0.32%-0.16%-0.08%0.16%-0.08%--0.24%0.08%0.40%
EPS (Basic)
1.631.762.461.571.061.431.001.29-3.341.151.750.840.811.311.430.910.020.302.061.21
EPS (Diluted)
1.611.742.431.561.041.421.001.29-3.341.141.730.830.801.301.420.910.020.302.051.21
EPS Growth (YoY)
54.81%22.54%143.00%20.93%-24.56%-42.20%55.42%--12.31%21.83%-8.79%3900.00%333.33%-30.73%-24.79%-98.54%-75.61%606.90%-
Free Cash Flow
2,4273,1223,9605301,6532,8284,1681,1942,1141,9521,6342,1981,6362,3862,7061,6591,5933,0523,1142,197
Free Cash Flow Growth (YoY)
46.82%10.40%-4.99%-55.61%-21.81%44.88%155.08%-45.68%29.22%-18.19%-39.62%32.49%2.70%-21.82%-13.10%-24.49%-34.85%68.90%48.64%-9.33%
Free Cash Flow Per Share
1.942.493.160.421.312.253.320.951.701.551.301.751.301.892.151.321.262.422.471.74
Dividends Per Share
0.8200.7900.7900.7900.7900.7700.7700.7700.7700.7500.7500.7500.7500.7300.7300.7300.7300.7100.7100.710
Dividend Growth (YoY)
3.80%2.60%2.60%2.60%2.60%2.67%2.67%2.67%2.67%2.74%2.74%2.74%2.74%2.82%2.82%2.82%2.82%4.41%4.41%4.41%
Gross Margin
79.24%79.51%79.80%78.81%76.90%79.11%79.14%77.80%76.79%70.62%77.80%78.15%77.94%81.11%80.19%76.96%78.39%63.74%83.52%77.64%
Operating Margin
37.16%25.03%42.82%34.93%33.55%32.40%11.77%38.02%-64.64%22.66%37.20%25.23%26.84%30.68%40.29%32.41%2.99%12.98%51.77%36.13%
Profit Margin
29.04%27.55%39.28%27.68%19.72%23.56%16.61%23.21%-62.37%19.92%30.80%15.74%15.51%22.10%25.36%18.13%0.18%5.19%34.85%24.40%
FCF Margin
34.87%39.39%50.97%7.48%24.79%37.36%55.24%17.17%31.62%27.44%23.17%33.31%25.76%32.29%38.43%26.50%24.17%42.13%41.96%35.34%
EBITDA
3,2752,6714,0133,1652,9333,1451,5783,338-3,6322,3003,3072,3462,3452,7953,3622,5547221,4754,3652,765
EBITDA Margin
47.05%33.70%51.65%44.69%43.99%41.55%20.91%48.00%-54.32%32.33%46.90%35.55%36.92%37.83%47.74%40.80%10.96%20.36%58.82%44.47%
EBIT
2,5861,9843,3272,4742,2372,4528882,644-4,3221,6122,6231,6651,7052,2672,8372,0291979403,8422,246
EBIT Margin
37.16%25.03%42.82%34.93%33.55%32.40%11.77%38.02%-64.64%22.66%37.20%25.23%26.84%30.68%40.29%32.41%2.99%12.98%51.77%36.13%
Effective Tax Rate
21.67%-5.05%16.18%19.27%20.25%17.77%-31.07%21.33%7.02%14.34%6.30%34.57%24.31%19.60%26.56%24.48%107.90%50.46%24.78%16.51%
SEC Filings: 10-K · 10-Q